Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder.

Trial Profile

Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Apr 2015

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 20 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 10 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top